Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DECS-II trial of intraoperative dexamethasone in cardiac surgery
NL-OMON55453Phase 4Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Oct 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dexamethasone in Systemic Inflammatory Response Syndrome (SIRS) (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Days alive and spent at home up to 30 days after surgery. Started Oct 2018; status: active, not recruiting.
02
Drugs
dexamethasone
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on NL-OMON55453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55453.